25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

000518 (Jiangsu Sihuan Bioengineering Co Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze Jiangsu Sihuan Bioengineering Co Ltd together

I guess you are interested in Jiangsu Sihuan Bioengineering Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Jiangsu Sihuan Bioengineering Co Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – Jiangsu Sihuan Bioengineering Co Ltd’s Price Targets

I'm going to help you getting a better view of Jiangsu Sihuan Bioengineering Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Jiangsu Sihuan Bioengineering Co Ltd

I send you an email if I find something interesting about Jiangsu Sihuan Bioengineering Co Ltd.

1. Quick Overview

1.1. Quick analysis of Jiangsu Sihuan Bioengineering Co Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Jiangsu Sihuan Bioengineering Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
95.0%

What is your share worth?

Current worth
¥0.48
Expected worth in 1 year
¥0.43
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
¥-0.05
Return On Investment
-2.1%

For what price can you sell your share?

Current Price per Share
¥2.26
Expected price per share
¥1.93 - ¥2.77
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Jiangsu Sihuan Bioengineering Co Ltd (5 min.)




Live pricePrice per Share (EOD)
¥2.26
Intrinsic Value Per Share
¥0.09 - ¥0.10
Total Value Per Share
¥0.57 - ¥0.59

2.2. Growth of Jiangsu Sihuan Bioengineering Co Ltd (5 min.)




Is Jiangsu Sihuan Bioengineering Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$68.5m$78m-$8.4m-12.2%

How much money is Jiangsu Sihuan Bioengineering Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.6m-$1.9m$350.8k21.9%
Net Profit Margin-21.6%-22.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Jiangsu Sihuan Bioengineering Co Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#394 / 913

Most Revenue
#321 / 913

Most Profit
#265 / 913

Most Efficient
#400 / 913
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Jiangsu Sihuan Bioengineering Co Ltd?

Welcome investor! Jiangsu Sihuan Bioengineering Co Ltd's management wants to use your money to grow the business. In return you get a share of Jiangsu Sihuan Bioengineering Co Ltd.

First you should know what it really means to hold a share of Jiangsu Sihuan Bioengineering Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Jiangsu Sihuan Bioengineering Co Ltd is ¥2.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Jiangsu Sihuan Bioengineering Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Jiangsu Sihuan Bioengineering Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥0.48. Based on the TTM, the Book Value Change Per Share is ¥-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Jiangsu Sihuan Bioengineering Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.00-0.1%0.00-0.1%0.000.0%0.000.0%
Usd Book Value Change Per Share0.000.0%0.00-0.1%0.00-0.1%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.00-0.1%0.00-0.1%0.000.0%0.000.0%
Usd Price Per Share0.33-0.36-0.40-0.47-0.64-
Price to Earnings Ratio-173.57--122.86--77.82--46.95-0.73-
Price-to-Total Gains Ratio-658.78--474.06--256.29--210.81--323.99-
Price to Book Ratio4.97-5.25-5.26-5.77-7.50-
Price-to-Total Gains Ratio-658.78--474.06--256.29--210.81--323.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.311428
Number of shares3211
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (3211 shares)-5.32-3.25
Gains per Year (3211 shares)-21.27-12.98
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-22-311-14-23
21-43-521-27-36
31-65-732-41-49
41-86-942-54-62
51-108-1153-68-75
62-129-1363-81-88
72-151-1574-95-101
82-173-1784-108-114
93-194-1995-122-127
103-216-2205-135-140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%13.019.08.032.5%50.019.019.056.8%
Book Value Change Per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%12.028.00.030.0%44.044.00.050.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%38.00.02.095.0%51.00.037.058.0%
Total Gains per Share0.04.00.00.0%0.012.00.00.0%5.015.00.025.0%13.027.00.032.5%47.041.00.053.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Jiangsu Sihuan Bioengineering Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.004-0.012+223%-0.015+290%-0.008+102%-0.006+67%
Book Value Per Share--0.4830.491-2%0.550-12%0.588-18%0.616-22%
Current Ratio--4.1684.287-3%4.591-9%4.748-12%2.812+48%
Debt To Asset Ratio--0.2350.227+4%0.208+13%0.203+15%0.245-4%
Debt To Equity Ratio--0.3260.312+5%0.280+16%0.274+19%0.360-9%
Dividend Per Share--0.0000.000-20%0.000-28%0.000-54%0.001-89%
Enterprise Value--2318588125.7202510874855.955-8%2831700402.495-18%3372516888.990-31%4590471606.212-49%
Eps---0.003-0.011+227%-0.012+260%-0.007+91%-0.002-32%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--11.55011.804-2%11.255+3%10.948+5%15.039-23%
Free Cash Flow Per Share--0.001-0.002+317%0.000+278%0.004-79%0.004-79%
Free Cash Flow To Equity Per Share--0.001-0.002+317%-0.002+357%-0.002+339%-0.002+339%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.800+25%
Intrinsic Value_10Y_max--0.104--------
Intrinsic Value_10Y_min--0.086--------
Intrinsic Value_1Y_max--0.001--------
Intrinsic Value_1Y_min--0.001--------
Intrinsic Value_3Y_max--0.010--------
Intrinsic Value_3Y_min--0.009--------
Intrinsic Value_5Y_max--0.028--------
Intrinsic Value_5Y_min--0.025--------
Market Cap2326805600.000-6%2470944000.0002658838700.000-7%2980576200.000-17%3526757780.000-30%4805993518.425-49%
Net Profit Margin---0.071-0.216+204%-0.226+218%-0.130+83%-0.053-26%
Operating Margin----0%-0.1840%-0.0660%-0.0400%
Operating Ratio--1.3751.462-6%1.456-6%1.399-2%0.996+38%
Pb Ratio4.679-6%4.9695.254-5%5.255-5%5.767-14%7.500-34%
Pe Ratio-163.442+6%-173.567-122.860-29%-77.824-55%-46.955-73%0.733-23783%
Price Per Share2.260-6%2.4002.583-7%2.895-17%3.426-30%4.667-49%
Price To Free Cash Flow Ratio722.003-6%766.729181.609+322%-174.073+123%-467.799+161%-233.899+131%
Price To Total Gains Ratio-620.347+6%-658.776-474.060-28%-256.293-61%-210.815-68%-323.990-51%
Quick Ratio--0.5140.564-9%0.874-41%0.917-44%0.836-38%
Return On Assets---0.005-0.018+223%-0.020+261%-0.010+84%-0.004-25%
Return On Equity---0.008-0.024+219%-0.027+249%-0.014+77%-0.005-30%
Total Gains Per Share---0.004-0.012+230%-0.015+300%-0.007+101%-0.005+39%
Usd Book Value--68520784.16069613676.658-2%78087200.938-12%83468704.908-18%87399223.668-22%
Usd Book Value Change Per Share---0.001-0.002+223%-0.002+290%-0.001+102%-0.001+67%
Usd Book Value Per Share--0.0670.068-2%0.076-12%0.081-18%0.085-22%
Usd Dividend Per Share--0.0000.000-20%0.000-28%0.000-54%0.000-89%
Usd Enterprise Value--319501443.724345998555.151-8%390208315.464-18%464732827.303-31%632566987.336-49%
Usd Eps--0.000-0.002+227%-0.002+260%-0.001+91%0.000-32%
Usd Free Cash Flow--111022.315-241116.964+317%29407.471+278%499178.468-78%249589.234-56%
Usd Free Cash Flow Per Share--0.0000.000+317%0.000+278%0.001-79%0.001-79%
Usd Free Cash Flow To Equity Per Share--0.0000.000+317%0.000+357%0.000+339%0.000+339%
Usd Market Cap320633811.680-6%340496083.200366387972.860-7%410723400.360-17%485987222.084-30%662265906.839-49%
Usd Price Per Share0.311-6%0.3310.356-7%0.399-17%0.472-30%0.643-49%
Usd Profit---490439.242-1604321.824+227%-1955196.132+299%-973708.231+99%-352366.662-28%
Usd Revenue--6915624.6987285409.468-5%8731644.293-21%11368600.257-39%11390127.381-39%
Usd Total Gains Per Share---0.001-0.002+230%-0.002+300%-0.001+101%-0.001+39%
 EOD+4 -4MRQTTM+19 -18YOY+20 -175Y+17 -2010Y+13 -25

3.3 Fundamental Score

Let's check the fundamental score of Jiangsu Sihuan Bioengineering Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-163.442
Price to Book Ratio (EOD)Between0-14.679
Net Profit Margin (MRQ)Greater than0-0.071
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.514
Current Ratio (MRQ)Greater than14.168
Debt to Asset Ratio (MRQ)Less than10.235
Debt to Equity Ratio (MRQ)Less than10.326
Return on Equity (MRQ)Greater than0.15-0.008
Return on Assets (MRQ)Greater than0.05-0.005
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Jiangsu Sihuan Bioengineering Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.495
Ma 20Greater thanMa 502.271
Ma 50Greater thanMa 1002.419
Ma 100Greater thanMa 2002.799
OpenGreater thanClose2.260
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Jiangsu Sihuan Bioengineering Co Ltd

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusen, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass; Xinde Lusheng; Xin Lisheng; and Ring BO. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China.

Fundamental data was last updated by Penke on 2025-03-22 21:18:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Jiangsu Sihuan Bioengineering Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Jiangsu Sihuan Bioengineering Co Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -7.1% means that ¥-0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The MRQ is -7.1%. The company is making a loss. -1
  • The TTM is -21.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-7.1%TTM-21.6%+14.5%
TTM-21.6%YOY-22.6%+1.0%
TTM-21.6%5Y-13.0%-8.6%
5Y-13.0%10Y-5.3%-7.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.1%-88.1%+81.0%
TTM-21.6%-190.6%+169.0%
YOY-22.6%-199.6%+177.0%
5Y-13.0%-336.0%+323.0%
10Y-5.3%-488.5%+483.2%
4.3.1.2. Return on Assets

Shows how efficient Jiangsu Sihuan Bioengineering Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Jiangsu Sihuan Bioengineering Co Ltd to the Biotechnology industry mean.
  • -0.5% Return on Assets means that Jiangsu Sihuan Bioengineering Co Ltd generated ¥-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The MRQ is -0.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.5%TTM-1.8%+1.2%
TTM-1.8%YOY-2.0%+0.2%
TTM-1.8%5Y-1.0%-0.8%
5Y-1.0%10Y-0.4%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.5%-11.9%+11.4%
TTM-1.8%-11.9%+10.1%
YOY-2.0%-11.6%+9.6%
5Y-1.0%-12.7%+11.7%
10Y-0.4%-14.3%+13.9%
4.3.1.3. Return on Equity

Shows how efficient Jiangsu Sihuan Bioengineering Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Jiangsu Sihuan Bioengineering Co Ltd to the Biotechnology industry mean.
  • -0.8% Return on Equity means Jiangsu Sihuan Bioengineering Co Ltd generated ¥-0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The MRQ is -0.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.8%TTM-2.4%+1.7%
TTM-2.4%YOY-2.7%+0.2%
TTM-2.4%5Y-1.4%-1.1%
5Y-1.4%10Y-0.5%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.8%-15.6%+14.8%
TTM-2.4%-15.8%+13.4%
YOY-2.7%-14.6%+11.9%
5Y-1.4%-18.0%+16.6%
10Y-0.5%-19.2%+18.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Jiangsu Sihuan Bioengineering Co Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Jiangsu Sihuan Bioengineering Co Ltd is operating .

  • Measures how much profit Jiangsu Sihuan Bioengineering Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Jiangsu Sihuan Bioengineering Co Ltd to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-18.4%+18.4%
TTM-5Y-6.6%+6.6%
5Y-6.6%10Y-4.0%-2.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--193.7%+193.7%
TTM--296.4%+296.4%
YOY-18.4%-206.9%+188.5%
5Y-6.6%-367.9%+361.3%
10Y-4.0%-475.9%+471.9%
4.3.2.2. Operating Ratio

Measures how efficient Jiangsu Sihuan Bioengineering Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.37 means that the operating costs are ¥1.37 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The MRQ is 1.375. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.462. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.375TTM1.462-0.087
TTM1.462YOY1.456+0.006
TTM1.4625Y1.399+0.063
5Y1.39910Y0.996+0.403
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3752.025-0.650
TTM1.4623.215-1.753
YOY1.4562.982-1.526
5Y1.3994.689-3.290
10Y0.9966.513-5.517
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Jiangsu Sihuan Bioengineering Co Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Jiangsu Sihuan Bioengineering Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.17 means the company has ¥4.17 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The MRQ is 4.168. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.287. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.168TTM4.287-0.119
TTM4.287YOY4.591-0.304
TTM4.2875Y4.748-0.461
5Y4.74810Y2.812+1.936
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1683.616+0.552
TTM4.2873.879+0.408
YOY4.5914.483+0.108
5Y4.7485.950-1.202
10Y2.8126.240-3.428
4.4.3.2. Quick Ratio

Measures if Jiangsu Sihuan Bioengineering Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Jiangsu Sihuan Bioengineering Co Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 0.51 means the company can pay off ¥0.51 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The MRQ is 0.514. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.564. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.514TTM0.564-0.050
TTM0.564YOY0.874-0.310
TTM0.5645Y0.917-0.352
5Y0.91710Y0.836+0.081
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5142.966-2.452
TTM0.5643.336-2.772
YOY0.8744.252-3.378
5Y0.9175.921-5.004
10Y0.8366.474-5.638
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Jiangsu Sihuan Bioengineering Co Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Jiangsu Sihuan Bioengineering Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Jiangsu Sihuan Bioengineering Co Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.23 means that Jiangsu Sihuan Bioengineering Co Ltd assets are financed with 23.5% credit (debt) and the remaining percentage (100% - 23.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The MRQ is 0.235. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.227. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.235TTM0.227+0.008
TTM0.227YOY0.208+0.018
TTM0.2275Y0.203+0.023
5Y0.20310Y0.245-0.041
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2350.340-0.105
TTM0.2270.340-0.113
YOY0.2080.312-0.104
5Y0.2030.359-0.156
10Y0.2450.382-0.137
4.5.4.2. Debt to Equity Ratio

Measures if Jiangsu Sihuan Bioengineering Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Jiangsu Sihuan Bioengineering Co Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 32.6% means that company has ¥0.33 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The MRQ is 0.326. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.312. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.326TTM0.312+0.014
TTM0.312YOY0.280+0.032
TTM0.3125Y0.274+0.038
5Y0.27410Y0.360-0.086
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3260.393-0.067
TTM0.3120.428-0.116
YOY0.2800.395-0.115
5Y0.2740.451-0.177
10Y0.3600.493-0.133
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Jiangsu Sihuan Bioengineering Co Ltd generates.

  • Above 15 is considered overpriced but always compare Jiangsu Sihuan Bioengineering Co Ltd to the Biotechnology industry mean.
  • A PE ratio of -173.57 means the investor is paying ¥-173.57 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The EOD is -163.442. Based on the earnings, the company is expensive. -2
  • The MRQ is -173.567. Based on the earnings, the company is expensive. -2
  • The TTM is -122.860. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-163.442MRQ-173.567+10.125
MRQ-173.567TTM-122.860-50.707
TTM-122.860YOY-77.824-45.036
TTM-122.8605Y-46.955-75.905
5Y-46.95510Y0.733-47.688
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-163.442-2.074-161.368
MRQ-173.567-2.522-171.045
TTM-122.860-3.216-119.644
YOY-77.824-3.300-74.524
5Y-46.955-6.225-40.730
10Y0.733-6.955+7.688
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The EOD is 722.003. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 766.729. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 181.609. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD722.003MRQ766.729-44.726
MRQ766.729TTM181.609+585.120
TTM181.609YOY-174.073+355.682
TTM181.6095Y-467.799+649.408
5Y-467.79910Y-233.899-233.899
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD722.003-2.854+724.857
MRQ766.729-3.511+770.240
TTM181.609-3.835+185.444
YOY-174.073-4.297-169.776
5Y-467.799-8.217-459.582
10Y-233.899-9.311-224.588
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Jiangsu Sihuan Bioengineering Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.97 means the investor is paying ¥4.97 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Jiangsu Sihuan Bioengineering Co Ltd:

  • The EOD is 4.679. Based on the equity, the company is fair priced.
  • The MRQ is 4.969. Based on the equity, the company is fair priced.
  • The TTM is 5.254. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD4.679MRQ4.969-0.290
MRQ4.969TTM5.254-0.285
TTM5.254YOY5.255-0.001
TTM5.2545Y5.767-0.512
5Y5.76710Y7.500-1.733
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.6791.874+2.805
MRQ4.9692.120+2.849
TTM5.2542.372+2.882
YOY5.2552.453+2.802
5Y5.7673.811+1.956
10Y7.5004.584+2.916
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets649,604
Total Liabilities152,356
Total Stockholder Equity467,090
 As reported
Total Liabilities 152,356
Total Stockholder Equity+ 467,090
Total Assets = 649,604

Assets

Total Assets649,604
Total Current Assets510,639
Long-term Assets138,965
Total Current Assets
Cash And Cash Equivalents 14,405
Short-term Investments 151
Net Receivables 62,856
Inventory 409,542
Other Current Assets 112
Total Current Assets  (as reported)510,639
Total Current Assets  (calculated)487,066
+/- 23,574
Long-term Assets
Property Plant Equipment 78,385
Intangible Assets 24,341
Long-term Assets  (as reported)138,965
Long-term Assets  (calculated)102,726
+/- 36,238

Liabilities & Shareholders' Equity

Total Current Liabilities122,507
Long-term Liabilities29,849
Total Stockholder Equity467,090
Total Current Liabilities
Short Long Term Debt 15,484
Accounts payable 54,720
Other Current Liabilities 6,904
Total Current Liabilities  (as reported)122,507
Total Current Liabilities  (calculated)77,108
+/- 45,399
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt26,987
Long-term Liabilities Other 2,862
Long-term Liabilities  (as reported)29,849
Long-term Liabilities  (calculated)29,849
+/- 0
Total Stockholder Equity
Total Stockholder Equity (as reported)467,090
Total Stockholder Equity (calculated)0
+/- 467,090
Other
Capital Stock1,029,556
Common Stock Shares Outstanding 1,029,556
Net Debt 1,080
Net Invested Capital 482,574
Net Working Capital 388,132
Property Plant and Equipment Gross 78,385



6.2. Balance Sheets Structured

Currency in CNY. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
234,000
274,672
402,652
1,081,944
1,121,069
1,156,683
1,151,469
1,144,996
1,163,525
1,214,543
1,171,408
1,230,232
1,361,248
1,381,891
1,389,260
1,348,723
1,245,390
1,217,691
1,295,466
1,130,622
1,185,169
1,186,078
1,228,532
1,266,489
1,187,277
1,149,928
883,262
896,111
944,389
945,201
776,067
791,315
864,922
747,833
752,694
754,914
758,560
765,140
962,042
974,781
981,215
977,296
969,936
968,408
983,355
880,732
912,853
925,711
928,870
914,683
822,584
836,874
833,904
842,870
818,082
848,932
847,893
855,443
834,528
1,025,801
1,077,533
1,099,712
1,017,358
1,214,507
924,282
945,937
931,628
921,776
924,583
904,070
925,876
895,384
883,539
894,602
915,826
855,605
810,490
813,019
823,708
823,331
817,763
805,917
799,312
741,996
759,907
757,659
738,078
712,877
712,555
698,674
660,975
653,491
648,501
649,604
649,604648,501653,491660,975698,674712,555712,877738,078757,659759,907741,996799,312805,917817,763823,331823,708813,019810,490855,605915,826894,602883,539895,384925,876904,070924,583921,776931,628945,937924,2821,214,5071,017,3581,099,7121,077,5331,025,801834,528855,443847,893848,932818,082842,870833,904836,874822,584914,683928,870925,711912,853880,732983,355968,408969,936977,296981,215974,781962,042765,140758,560754,914752,694747,833864,922791,315776,067945,201944,389896,111883,2621,149,9281,187,2771,266,4891,228,5321,186,0781,185,1691,130,6221,295,4661,217,6911,245,3901,348,7231,389,2601,381,8911,361,2481,230,2321,171,4081,214,5431,163,5251,144,9961,151,4691,156,6831,121,0691,081,944402,652274,672234,000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
761,637
745,260
763,389
736,764
709,664
729,911
755,852
700,487
658,020
658,746
668,929
628,052
631,313
623,377
620,441
567,869
574,431
564,820
564,820
544,569
548,937
544,708
509,380
506,026
505,712
510,639
510,639505,712506,026509,380544,708548,937544,569564,820564,820574,431567,869620,441623,377631,313628,052668,929658,746658,020700,487755,852729,911709,664736,764763,389745,260761,63700000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47,301
33,981
39,430
23,352
16,205
33,409
53,081
32,237
27,591
38,417
54,591
35,891
39,470
38,157
38,111
28,796
28,416
31,601
28,180
25,638
21,875
20,711
18,927
16,499
11,038
14,405
14,40511,03816,49918,92720,71121,87525,63828,18031,60128,41628,79638,11138,15739,47035,89154,59138,41727,59132,23753,08133,40916,20523,35239,43033,98147,30100000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
0
0
0
0
0
226
206
175
133
161
153
146
136
136
159
142
151
15114215913613614615316113317520622600000100000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
55,040
65,187
56,883
135,501
129,912
130,144
193,515
112,115
146,149
164,748
142,563
149,999
144,239
122,340
254,089
231,699
135,772
177,247
240,022
205,323
203,876
211,798
248,348
254,108
203,527
192,711
258,564
257,146
216,909
212,778
145,974
144,458
119,081
126,476
93,131
105,711
107,504
105,687
91,368
118,446
115,630
108,658
196,018
214,711
223,009
109,903
151,810
150,424
117,184
118,420
88,890
203,538
226,305
229,076
233,354
232,353
167,780
153,138
177,135
166,522
172,103
176,701
141,931
171,410
138,468
139,471
140,953
143,659
132,000
137,323
139,262
116,256
113,577
126,152
140,981
170,995
137,830
145,453
157,114
140,561
136,038
128,554
142,288
105,576
99,436
119,479
119,479
100,118
102,338
96,357
69,818
65,732
68,239
62,856
62,85668,23965,73269,81896,357102,338100,118119,479119,47999,436105,576142,288128,554136,038140,561157,114145,453137,830170,995140,981126,152113,577116,256139,262137,323132,000143,659140,953139,471138,468171,410141,931176,701172,103166,522177,135153,138167,780232,353233,354229,076226,305203,53888,890118,420117,184150,424151,810109,903223,009214,711196,018108,658115,630118,44691,368105,687107,504105,71193,131126,476119,081144,458145,974212,778216,909257,146258,564192,711203,527254,108248,348211,798203,876205,323240,022177,247135,772231,699254,089122,340144,239149,999142,563164,748146,149112,115193,515130,144129,912135,50156,88365,18755,040
       Other Current Assets 
30,503
37,267
89,813
70,113
56,603
73,822
152,766
24,325
55,181
98,558
41,929
25,338
36,747
10,572
49,124
45,956
49,854
25,066
71,196
33,131
31,997
27,140
43,418
11,274
3,894
3,281
4,464
8,924
88,390
143,361
145,946
204,073
142,140
53,950
53,529
52,547
53,415
3,903
88,065
128,385
132,661
71,975
65,961
69,906
66,841
73,044
75,640
88,423
181,722
186,436
172,742
71,554
58,187
168,720
38,180
37,152
46,561
80,755
29,660
28,923
7,912
6,095
7,417
16,489
6,349
15,133
3,995
4,620
7,927
10,742
4,092
818
2,454
18
5,300
6,525
9,682
8,231
5,787
7,713
13,235
15,824
5,750
9,851
10,484
4,792
4,792
8,038
5,279
11,481
195
113
112
112
11211211319511,4815,2798,0384,7924,79210,4849,8515,75015,82413,2357,7135,7878,2319,6826,5255,300182,4548184,09210,7427,9274,6203,99515,1336,34916,4897,4176,0957,91228,92329,66080,75546,56137,15238,180168,72058,18771,554172,742186,436181,72288,42375,64073,04466,84169,90665,96171,975132,661128,38588,0653,90353,41552,54753,52953,950142,140204,073145,946143,36188,3908,9244,4643,2813,89411,27443,41827,14031,99733,13171,19625,06649,85445,95649,12410,57236,74725,33841,92998,55855,18124,325152,76673,82256,60370,11389,81337,26730,503
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
158,620
173,875
164,691
159,974
155,118
152,470
154,273
154,779
195,279
186,450
182,540
178,871
174,127
185,476
179,559
173,259
168,308
163,619
153,966
151,595
147,466
142,789
138,965
138,965142,789147,466151,595153,966163,619168,308173,259179,559185,476174,127178,871182,540186,450195,279154,779154,273152,470155,118159,974164,691173,875158,62000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
71,574
74,112
86,556
231,609
236,251
245,808
209,920
294,873
278,100
292,583
304,610
321,037
312,610
327,847
340,265
349,618
441,974
419,796
480,137
427,480
473,245
434,626
577,414
411,216
448,228
389,161
349,406
313,259
342,347
306,221
300,937
265,323
294,056
268,255
288,937
263,357
281,603
255,567
271,453
247,605
264,242
256,191
290,054
245,614
284,423
241,353
291,951
246,336
283,924
237,526
278,214
236,421
233,817
233,132
330,170
328,322
315,931
307,766
303,971
302,143
301,438
290,326
241,834
237,640
74,811
73,380
79,881
79,689
87,081
86,490
89,493
87,907
103,305
89,566
80,930
78,023
76,774
79,797
84,490
126,679
119,626
117,519
92,040
90,027
89,996
86,439
85,062
81,401
79,569
76,886
84,093
82,045
80,095
78,385
78,38580,09582,04584,09376,88679,56981,40185,06286,43989,99690,02792,040117,519119,626126,67984,49079,79776,77478,02380,93089,566103,30587,90789,49386,49087,08179,68979,88173,38074,811237,640241,834290,326301,438302,143303,971307,766315,931328,322330,170233,132233,817236,421278,214237,526283,924246,336291,951241,353284,423245,614290,054256,191264,242247,605271,453255,567281,603263,357288,937268,255294,056265,323300,937306,221342,347313,259349,406389,161448,228411,216577,414434,626473,245427,480480,137419,796441,974349,618340,265327,847312,610321,037304,610292,583278,100294,873209,920245,808236,251231,60986,55674,11271,574
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,500
1,500
1,376
1,333
1,300
1,253
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001,2531,3001,3331,3761,5001,50000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
150,118
146,478
153,262
149,462
163,034
159,234
155,303
151,426
161,243
152,099
147,526
148,625
128,746
165,492
119,214
123,542
77,558
134,254
79,040
29,725
132,215
133,642
125,384
0
61,308
0
56,206
0
31,569
7,710
28,512
4,987
25,974
2,494
23,235
148,793
168,883
145,672
268,654
129,358
176,024
124,537
170,681
119,717
165,436
114,992
160,088
50,756
119,914
118,455
116,077
101,985
100,141
98,297
96,487
59,103
78,048
76,659
75,271
69,344
72,986
37,850
36,695
45,640
44,221
42,801
41,381
39,962
38,542
33,695
42,194
49,765
48,110
46,705
45,300
44,029
42,624
41,219
39,727
41,290
39,485
51,030
49,601
46,646
45,053
43,461
37,276
30,008
27,869
26,230
24,341
24,34126,23027,86930,00837,27643,46145,05346,64649,60151,03039,48541,29039,72741,21942,62444,02945,30046,70548,11049,76542,19433,69538,54239,96241,38142,80144,22145,64036,69537,85072,98669,34475,27176,65978,04859,10396,48798,297100,141101,985116,077118,455119,91450,756160,088114,992165,436119,717170,681124,537176,024129,358268,654145,672168,883148,79323,2352,49425,9744,98728,5127,71031,569056,206061,3080125,384133,642132,21529,72579,040134,25477,558123,542119,214165,492128,746148,625147,526152,099161,243151,426155,303159,234163,034149,462153,262146,478150,118000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
158,620
173,875
164,691
159,974
155,118
0
79,797
0
0
0
0
2,000
2,000
2,000
2,000
0
0
0
0
0
0
0
0
000000002,0002,0002,0002,000000079,7970155,118159,974164,691173,875158,62000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
41,439
69,839
151,071
98,903
109,008
113,074
84,293
82,395
79,247
97,336
73,397
134,534
215,383
234,588
282,432
241,478
137,807
129,965
292,560
125,572
171,197
171,627
217,361
249,187
176,267
144,317
49,498
61,151
106,221
100,497
83,207
85,147
163,821
43,691
40,317
40,162
42,212
44,392
82,318
91,724
94,504
45,776
54,174
50,883
60,839
54,330
82,611
99,752
102,575
86,387
91,806
94,564
81,881
85,743
96,491
117,689
124,055
147,282
225,839
420,472
474,123
481,990
406,263
530,101
240,079
244,849
256,083
241,066
249,390
240,201
283,074
266,452
250,709
239,851
255,512
186,998
145,653
133,939
138,660
153,252
164,285
146,650
152,536
121,129
149,337
149,509
144,583
140,504
159,180
151,236
148,195
143,941
147,364
152,356
152,356147,364143,941148,195151,236159,180140,504144,583149,509149,337121,129152,536146,650164,285153,252138,660133,939145,653186,998255,512239,851250,709266,452283,074240,201249,390241,066256,083244,849240,079530,101406,263481,990474,123420,472225,839147,282124,055117,68996,49185,74381,88194,56491,80686,387102,57599,75282,61154,33060,83950,88354,17445,77694,50491,72482,31844,39242,21240,16240,31743,691163,82185,14783,207100,497106,22161,15149,498144,317176,267249,187217,361171,627171,197125,572292,560129,965137,807241,478282,432234,588215,383134,53473,39797,33679,24782,39584,293113,074109,00898,903151,07169,83941,439
   > Total Current Liabilities 
41,283
69,683
150,915
98,747
108,853
112,918
84,137
82,239
79,090
96,777
73,241
134,378
215,227
234,432
282,276
241,322
137,652
129,809
292,404
125,416
171,041
170,971
217,028
248,855
174,435
143,393
47,822
59,415
104,485
98,761
80,608
85,147
163,821
43,691
40,317
40,162
42,212
44,392
81,518
90,924
93,707
44,979
52,226
48,935
58,115
52,582
79,333
96,475
99,297
83,109
86,343
88,100
75,418
78,741
91,598
112,708
119,073
144,100
209,272
403,905
457,555
465,897
405,270
526,647
237,817
243,191
253,875
239,032
248,192
239,495
282,695
266,117
250,399
239,574
253,774
185,281
144,004
132,290
137,660
107,427
121,906
103,832
120,931
89,305
117,236
116,217
116,217
112,062
130,688
122,555
118,149
115,046
118,398
122,507
122,507118,398115,046118,149122,555130,688112,062116,217116,217117,23689,305120,931103,832121,906107,427137,660132,290144,004185,281253,774239,574250,399266,117282,695239,495248,192239,032253,875243,191237,817526,647405,270465,897457,555403,905209,272144,100119,073112,70891,59878,74175,41888,10086,34383,10999,29796,47579,33352,58258,11548,93552,22644,97993,70790,92481,51844,39242,21240,16240,31743,691163,82185,14780,60898,761104,48559,41547,822143,393174,435248,855217,028170,971171,041125,416292,404129,809137,652241,322282,276234,432215,227134,37873,24196,77779,09082,23984,137112,918108,85398,747150,91569,68341,283
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70,000
66,000
66,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000066,00066,00070,00000000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70,000
66,000
66,000
16,017
16,017
16,012
16,015
16,016
16,016
16,013
16,013
16,007
16,000
16,000
16,000
16,000
16,000
16,000
16,000
16,017
16,017
15,484
15,484
15,48415,48416,01716,01716,00016,00016,00016,00016,00016,00016,00016,00716,01316,01316,01616,01616,01516,01216,01716,01766,00066,00070,00000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
4,500
2,455
1,185
16,018
26,529
24,953
31,132
21,948
18,126
23,224
6,530
26,423
23,605
32,576
127,317
48,887
42,721
25,152
92,617
23,108
47,650
31,603
25,449
42,231
44,686
26,879
11,153
15,176
13,961
9,940
7,853
12,515
13,983
13,717
14,157
17,931
17,604
15,098
13,273
21,515
19,932
17,856
13,300
13,792
17,235
17,782
17,307
11,825
14,690
11,623
14,475
13,445
13,570
19,248
25,629
16,635
22,039
34,075
84,267
273,148
323,533
321,727
313,106
306,672
91,512
29,448
19,103
19,541
22,154
31,512
60,479
44,340
49,184
51,358
63,351
61,028
60,251
38,961
57,634
36,210
53,470
34,930
60,766
32,213
62,515
52,698
52,698
55,487
65,640
59,541
49,889
50,044
51,297
54,720
54,72051,29750,04449,88959,54165,64055,48752,69852,69862,51532,21360,76634,93053,47036,21057,63438,96160,25161,02863,35151,35849,18444,34060,47931,51222,15419,54119,10329,44891,512306,672313,106321,727323,533273,14884,26734,07522,03916,63525,62919,24813,57013,44514,47511,62314,69011,82517,30717,78217,23513,79213,30017,85619,93221,51513,27315,09817,60417,93114,15713,71713,98312,5157,8539,94013,96115,17611,15326,87944,68642,23125,44931,60347,65023,10892,61725,15242,72148,887127,31732,57623,60526,4236,53023,22418,12621,94831,13224,95326,52916,0181,1852,4554,500
       Other Current Liabilities 
29,033
41,278
53,780
79,379
78,974
84,615
49,655
56,941
57,614
71,503
64,661
55,905
49,572
59,806
62,909
100,385
52,881
62,607
58,137
50,257
71,341
67,318
59,529
74,574
57,699
44,464
34,619
42,189
38,474
36,771
21,005
21,882
99,088
28,224
24,410
20,481
22,858
27,544
68,245
69,409
73,775
27,123
38,926
35,143
40,880
34,800
62,026
69,650
69,607
57,987
62,313
67,426
35,530
57,041
64,310
60,241
62,034
75,026
64,638
120,757
124,022
101,171
39,164
166,975
146,305
163,743
184,772
169,491
149,235
187,164
143,228
151,405
128,698
121,922
164,273
107,617
59,832
77,044
55,912
54,965
48,175
52,674
31,887
36,606
25,695
30,782
30,782
33,556
39,837
42,210
8,536
5,218
7,692
6,904
6,9047,6925,2188,53642,21039,83733,55630,78230,78225,69536,60631,88752,67448,17554,96555,91277,04459,832107,617164,273121,922128,698151,405143,228187,164149,235169,491184,772163,743146,305166,97539,164101,171124,022120,75764,63875,02662,03460,24164,31057,04135,53067,42662,31357,98769,60769,65062,02634,80040,88035,14338,92627,12373,77569,40968,24527,54422,85820,48124,41028,22499,08821,88221,00536,77138,47442,18934,61944,46457,69974,57459,52967,31871,34150,25758,13762,60752,881100,38562,90959,80649,57255,90564,66171,50357,61456,94149,65584,61578,97479,37953,78041,27829,033
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
334
309
276
1,737
1,717
1,649
1,649
1,000
45,825
42,379
42,818
31,605
31,825
32,101
32,359
28,366
28,442
28,492
28,681
30,045
28,895
28,965
29,849
29,84928,96528,89530,04528,68128,49228,44228,36632,35932,10131,82531,60542,81842,37945,8251,0001,6491,6491,7171,73727630933400000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-70,000
-66,000
-66,000
0
0
0
0
0
44,825
41,379
41,818
30,803
31,023
31,299
31,556
28,366
28,442
28,305
28,494
26,473
26,493
26,633
26,987
26,98726,63326,49326,47328,49428,30528,44228,36631,55631,29931,02330,80341,81841,37944,82500000-66,000-66,000-70,00000000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
334
309
276
1,737
1,717
1,649
1,649
1,000
1,000
1,000
1,000
802
802
802
802
0
0
187
187
3,572
2,403
2,333
2,862
2,8622,3332,4033,572187187008028028028021,0001,0001,0001,0001,6491,6491,7171,73727630933400000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,254
2,891
3,891
3,297
3,821
3,835
15,237
15,227
15,217
15,207
15,000
15,000
15,000
15,000
17,980
17,980
30,580
15,580
15,580
15,580
15,580
10,980
0
0
0
0
000010,98015,58015,58015,58015,58030,58017,98017,98015,00015,00015,00015,00015,20715,21715,22715,2373,8353,8213,2973,8912,8913,25400000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
192,561
204,834
248,842
980,006
1,008,855
1,040,266
1,064,040
1,059,000
1,080,417
1,113,583
1,094,339
1,092,080
1,142,187
1,143,676
1,103,302
1,103,748
1,104,090
1,084,283
999,762
1,001,909
1,002,983
1,003,665
1,004,934
1,011,318
1,005,268
1,000,122
828,909
830,299
833,674
840,466
689,035
706,168
701,101
704,142
712,377
714,752
716,347
720,748
716,401
717,633
718,540
725,747
710,438
710,637
711,951
738,940
745,824
742,875
744,642
747,805
675,111
687,944
697,977
703,796
681,068
691,166
685,165
676,443
606,622
605,667
601,708
616,990
611,095
632,054
640,442
654,969
628,637
632,203
629,666
619,245
599,198
586,405
589,824
608,674
613,528
623,838
619,825
635,280
640,824
627,556
613,154
618,042
606,034
582,758
573,106
570,678
557,241
538,282
519,465
513,923
481,707
478,740
470,649
467,090
467,090470,649478,740481,707513,923519,465538,282557,241570,678573,106582,758606,034618,042613,154627,556640,824635,280619,825623,838613,528608,674589,824586,405599,198619,245629,666632,203628,637654,969640,442632,054611,095616,990601,708605,667606,622676,443685,165691,166681,068703,796697,977687,944675,111747,805744,642742,875745,824738,940711,951710,637710,438725,747718,540717,633716,401720,748716,347714,752712,377704,142701,101706,168689,035840,466833,674830,299828,9091,000,1221,005,2681,011,3181,004,9341,003,6651,002,9831,001,909999,7621,084,2831,104,0901,103,7481,103,3021,143,6761,142,1871,092,0801,094,3391,113,5831,080,4171,059,0001,064,0401,040,2661,008,855980,006248,842204,834192,561
   Common Stock
133,742
133,742
133,742
178,742
285,988
285,988
514,778
514,778
514,778
514,778
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
1,029,556
0
0
0
0
00001,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,5561,029,556514,778514,778514,778514,778285,988285,988178,742133,742133,742133,742
   Retained Earnings 
133
0
33,966
56,457
79,943
111,354
122,384
115,932
134,136
130,704
23,050
17,084
59,675
60,941
26,610
26,989
27,280
7,591
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-436,340
-446,761
-466,809
-517,458
-514,039
-495,189
-452,478
-442,169
-446,181
-430,726
-425,183
-438,451
-452,852
-447,964
-459,973
-483,248
-492,900
-508,765
-508,765
-527,724
-546,541
-552,083
-621,892
-624,859
-632,950
-636,509
-636,509-632,950-624,859-621,892-552,083-546,541-527,724-508,765-508,765-492,900-483,248-459,973-447,964-452,852-438,451-425,183-430,726-446,181-442,169-452,478-495,189-514,039-517,458-466,809-446,761-436,340000000000000000000000000000000000000000000000000007,59127,28026,98926,61060,94159,67517,08423,050130,704134,136115,932122,384111,35479,94356,45733,9660133
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
877
877
877
877
877
877
877
877
877
877
877
877
877
877
877
877
877
877
877
877
877
877
0
0
0
0
000087787787787787787787787787787787787787787787787787787787787787787700000000000000000000000000000000000000000000000000000000000000000000



6.3. Balance Sheets

Currency in CNY. All numbers in thousands.




6.4. Cash Flows

Currency in CNY. All numbers in thousands.




6.5. Income Statements

Currency in CNY. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in CNY. All numbers in thousands.

Gross Profit (+$)
totalRevenue235,419
Cost of Revenue-71,187
Gross Profit164,232164,232
 
Operating Income (+$)
Gross Profit164,232
Operating Expense-285,185
Operating Income-49,766-120,954
 
Operating Expense (+$)
Research Development31,167
Selling General Administrative139,222
Selling And Marketing Expenses-
Operating Expense285,185170,389
 
Net Interest Income (+$)
Interest Income45
Interest Expense-909
Other Finance Cost-1,597
Net Interest Income-2,461
 
Pretax Income (+$)
Operating Income-49,766
Net Interest Income-2,461
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-79,425-49,766
EBIT - interestExpense = -909
-75,270
-74,361
Interest Expense909
Earnings Before Interest and Taxes (EBIT)--78,517
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-79,425
Tax Provision-989
Net Income From Continuing Ops-80,415-80,415
Net Income-75,270
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-2,461
 

Technical Analysis of Jiangsu Sihuan Bioengineering Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Jiangsu Sihuan Bioengineering Co Ltd. The general trend of Jiangsu Sihuan Bioengineering Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Jiangsu Sihuan Bioengineering Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Jiangsu Sihuan Bioengineering Co Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Jiangsu Sihuan Bioengineering Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.38 < 2.7 < 2.77.

The bearish price targets are: 2.15 > 2.1 > 1.93.

Know someone who trades $000518? Share this with them.👇

Jiangsu Sihuan Bioengineering Co Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Jiangsu Sihuan Bioengineering Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Jiangsu Sihuan Bioengineering Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Jiangsu Sihuan Bioengineering Co Ltd. The current macd is -0.0514705.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Jiangsu Sihuan Bioengineering Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Jiangsu Sihuan Bioengineering Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Jiangsu Sihuan Bioengineering Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Jiangsu Sihuan Bioengineering Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartJiangsu Sihuan Bioengineering Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Jiangsu Sihuan Bioengineering Co Ltd. The current adx is 12.78.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Jiangsu Sihuan Bioengineering Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Jiangsu Sihuan Bioengineering Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Jiangsu Sihuan Bioengineering Co Ltd. The current sar is 2.14178635.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Jiangsu Sihuan Bioengineering Co Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Jiangsu Sihuan Bioengineering Co Ltd. The current rsi is 41.49. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Jiangsu Sihuan Bioengineering Co Ltd Daily Relative Strength Index (RSI) ChartJiangsu Sihuan Bioengineering Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Jiangsu Sihuan Bioengineering Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Jiangsu Sihuan Bioengineering Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Jiangsu Sihuan Bioengineering Co Ltd Daily Stochastic Oscillator ChartJiangsu Sihuan Bioengineering Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Jiangsu Sihuan Bioengineering Co Ltd. The current cci is -30.67207939.

Jiangsu Sihuan Bioengineering Co Ltd Daily Commodity Channel Index (CCI) ChartJiangsu Sihuan Bioengineering Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Jiangsu Sihuan Bioengineering Co Ltd. The current cmo is -16.08271906.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Jiangsu Sihuan Bioengineering Co Ltd Daily Chande Momentum Oscillator (CMO) ChartJiangsu Sihuan Bioengineering Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Jiangsu Sihuan Bioengineering Co Ltd. The current willr is -57.14285714.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Jiangsu Sihuan Bioengineering Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Jiangsu Sihuan Bioengineering Co Ltd Daily Williams %R ChartJiangsu Sihuan Bioengineering Co Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Jiangsu Sihuan Bioengineering Co Ltd.

Jiangsu Sihuan Bioengineering Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Jiangsu Sihuan Bioengineering Co Ltd. The current atr is 0.08821769.

Jiangsu Sihuan Bioengineering Co Ltd Daily Average True Range (ATR) ChartJiangsu Sihuan Bioengineering Co Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Jiangsu Sihuan Bioengineering Co Ltd. The current obv is 26,555,552.

Jiangsu Sihuan Bioengineering Co Ltd Daily On-Balance Volume (OBV) ChartJiangsu Sihuan Bioengineering Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Jiangsu Sihuan Bioengineering Co Ltd. The current mfi is 60.17.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Jiangsu Sihuan Bioengineering Co Ltd Daily Money Flow Index (MFI) ChartJiangsu Sihuan Bioengineering Co Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Jiangsu Sihuan Bioengineering Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-05MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-07CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-27STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Jiangsu Sihuan Bioengineering Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Jiangsu Sihuan Bioengineering Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.495
Ma 20Greater thanMa 502.271
Ma 50Greater thanMa 1002.419
Ma 100Greater thanMa 2002.799
OpenGreater thanClose2.260
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Jiangsu Sihuan Bioengineering Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Jiangsu Sihuan Bioengineering Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Jiangsu Sihuan Bioengineering Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Jiangsu Sihuan Bioengineering Co Ltd

I send you an email if I find something interesting about Jiangsu Sihuan Bioengineering Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Jiangsu Sihuan Bioengineering Co Ltd.

Receive notifications about Jiangsu Sihuan Bioengineering Co Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.